financetom
Business
financetom
/
Business
/
Ford Motor Q3 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ford Motor Q3 Adjusted Earnings, Revenue Increase
Nov 3, 2024 1:06 PM

04:29 PM EDT, 10/28/2024 (MT Newswires) -- Ford Motor ( F ) reported Q3 adjusted earnings late Monday of $0.49 per diluted share, up from $0.39 a year earlier.

Analysts polled by Capital IQ expected $0.47.

Revenue in the quarter ended Sept. 30 rose to $46.20 billion from $43.80 billion a year earlier.

Analysts surveyed by Capital IQ expected $42.32 billion.

The company kept its quarterly dividend at $0.15 per share, payable on Dec. 2 to shareholders of record on Nov. 7

Shares of Ford Motor ( F ) slumped 4.5% in after-hours activity.

Price: 10.86, Change: -0.51, Percent Change: -4.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Salesforce Q1 Results Likely to Exceed Low Expectations, Oppenheimer Says
Salesforce Q1 Results Likely to Exceed Low Expectations, Oppenheimer Says
May 23, 2024
02:40 PM EDT, 05/23/2024 (MT Newswires) -- Salesforce ( CRM ) fiscal Q1 results are expected to surpass already low expectations, Oppenheimer said in a note Thursday. The company expects Q1 adjusted earnings per share of $2.37 to $2.39 on revenue of $9.12 billion to $9.17 billion. Salesforce ( CRM ) is expected to report Q1 results on Wednesday, and...
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
May 23, 2024
On Wednesday, Royalty Pharma plc ( RPRX ) and Cytokinetics ( CYTK ) Incorporated entered into a strategic funding collaboration providing capital to support the commercialization of aficamten and advance the company’s expanding cardiovascular pipeline. The transaction includes funding for planned commercialization, development funding, royalty restructuring, revenue sharing, and the purchase of Cytokinetics ( CYTK ) equity.  Together, these provide Cytokinetics ( CYTK ) with $250 million on...
Greenwave Technology Shares Jump After Eliminating All Convertible Debt
Greenwave Technology Shares Jump After Eliminating All Convertible Debt
May 23, 2024
02:39 PM EDT, 05/23/2024 (MT Newswires) -- Greenwave Technology Solutions ( GWAV ) shares were up more than 11% in recent Thursday trading after the company said late Wednesday it has retired all of its convertible debt and preferred shares. Since the beginning of 2024, the company said it has eliminated $35.2 million in debt, including $17.2 million of debt...
Charter Communications Prices Tender Offer for Senior Secured Notes due 2025
Charter Communications Prices Tender Offer for Senior Secured Notes due 2025
May 23, 2024
02:43 PM EDT, 05/23/2024 (MT Newswires) -- Charter Communications ( CHTR ) said Thursday it has determined a total early offer consideration of $993.94 per $1,000 principal amount of notes in the tender offer for the company's outstanding 4.908% senior secured notes due 2025. The tender offer comprises the offer to purchase for cash up to $2.7 billion, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved